Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK Genomics Medicine Start-up Congenica Ltd Wins Genomics England Competition

Published: Tuesday, May 06, 2014
Last Updated: Tuesday, May 06, 2014
Bookmark and Share
Funding to be used by Congenica to further develop it’s SAPIENTIA™ platform.

Cambridge based Congenica Ltd has announced that it has been one of several Small Business Research Initiative competition awards funded by the UK Department of Health and managed by Genomics England.

This funding will be used by Congenica to further develop it’s SAPIENTIA™ platform that provides a novel, modular, and scalable data analytics pipeline for the annotation and clinical interpretation of genomic sequence data in both human genetic disease testing and research environments.

Tom Weaver, Congenica’s CEO, said: “Winning this competition is very important for a small start-up company like ours as it demonstrates our potential and a measure of how critical the analysis tools we are developing will be for supporting national scale screening projects, including Genomics England’s fantastic ambition to sequence 100,000 genomes in a clinical context.”

Data analytics that allow the intelligent interpretation of genome sequence and clinical phenotypes in a safe, affordable and scalable manner is the next challenge as genomic technology transforms the way doctors diagnose disease and decide on the best treatment choices.

Congenica’s first product is built upon world leading technology developed by the Wellcome Trust Sanger Institute that has delivered many thousands of genomes and it is the company’s vision to apply this technology in the clinic in order to make a real difference in the treatment and outcome of patients with genetic disease.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Congenica’s Diagnostic Technology Validated by Genomics England
Company selected as one of the winners of a whole genome annotation assessment.
Thursday, October 16, 2014
Congenica and Northern Health Science Alliance Announces Partnership
Partnership set to accelerate development of diagnostic tools and improve outcomes for patients.
Saturday, May 10, 2014
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!